During the past decade, QEII - HSC Department of Ophthalmology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "QEII - HSC Department of Ophthalmology" are "Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "QEII - HSC Department of Ophthalmology" in a lesser frequency.

Most popular intervention types in "QEII - HSC Department of Ophthalmology" are "Drug" (3 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Lampalizumab" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "QEII - HSC Department of Ophthalmology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "QEII - HSC Department of Ophthalmology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in QEII - HSC Department of Ophthalmology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in QEII - HSC Department of Ophthalmology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".